[VIEW] agent=Marketing Analytics & Media Planning Lead | scenario_id=74 | rounds=20

--- Round 0 ---
[R0.1] Theatrical & Windowing Strategy Director (speak, public): Let's discuss the release strategy for our mid-budget thriller. We're currently planning a wide theatrical release on Oct 9, 2026, with an exclusive window of 45 days. What are your thoughts on the marketing effectiveness and any potential constraints we should consider?
[R0.2] Marketing Analytics & Media Planning Lead (speak, public): To assess marketing effectiveness, we need to consider our current campaign performance and audience awareness. Our teaser completion rate is 41% and click-through rate is 1.3%, which are decent starting points. However, unaided awareness among our target demographic of 18-34-year-olds is currently at 16%, slightly below our target benchmark of 22%. We should discuss how a wide theatrical release versus a hybrid theatrical-to-PVOD window could impact our marketing ROI and whether there are any contractual or legal constraints we need to be aware of.
[R0.3] Legal & Business Affairs Counsel (speak, public): To ensure we're compliant and optimizing our commercial outcome, can you clarify the planned scale assumptions for the wide theatrical release on Oct 9, 2026, and confirm if there are any undisclosed commercial commitments or internal trigger thresholds that could impact our decision?

--- Round 1 ---
[R1.1] Theatrical & Windowing Strategy Director (speak, public): We've got a wide theatrical release planned for Oct 9, 2026, with an exclusive 45-day window. Our international presales are looking good, with UK/Ireland minimum guarantee at $4.2M. However, I'm concerned about the demand indicators - our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. I'd like to discuss how a hybrid theatrical-to-PVOD window could mitigate some of that risk. Have you considered the contractual implications of altering our release strategy?
[R1.2] Marketing Analytics & Media Planning Lead (speak, public): To better understand the implications of altering our release strategy, I'd like to share some additional context on our marketing efforts. Our paid media budget is planned at $14.0M, with 60% allocated to digital video. We've seeded 35 influencers as part of our creator activation plan, with the embargo lifting on Sep 20, 2026. Can we discuss how a hybrid theatrical-to-PVOD window might affect our influencer partnerships and overall marketing ROI? Additionally, are there any specific contractual implications or legal constraints we should be aware of when considering a change in our release strategy?
[R1.3] Legal & Business Affairs Counsel (speak, public): To better understand the implications of a hybrid theatrical-to-PVOD window, can you clarify the ad-placement guardrails for our $14.0M paid media budget and provide more details on the creator rollout plan, including any contractual obligations tied to the influencer partnerships? Additionally, are there any other commercial commitments or internal trigger thresholds we should be aware of that could impact our decision?

--- Round 2 ---
[R2.1] Theatrical & Windowing Strategy Director (speak, public): Our current plan is to release the film wide on Oct 9, 2026, with a 45-day exclusive window. However, we're considering an alternative hybrid theatrical-to-PVOD window, where the film would be available on PVOD on day 18. I'd like to discuss the potential impact on our marketing ROI and any contractual implications. We've seen T-30 presales at 62,000 tickets, which is below the comp-set median. Can you provide more insight into how our marketing efforts could be affected by a change in release strategy?
[R2.2] Marketing Analytics & Media Planning Lead (speak, public): To assess the impact on our marketing ROI, we need to consider how a hybrid theatrical-to-PVOD window could affect our paid media budget allocation and influencer partnerships. Our current plan has 60% of the $14.0M budget allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. A shorter theatrical window could potentially alter our messaging and creative assets. I'd like to discuss the contractual implications with Legal & Business Affairs Counsel to ensure we're compliant with our influencer partnerships and other commercial commitments.
[R2.3] Legal & Business Affairs Counsel (speak, public): To ensure we're compliant and optimizing our commercial outcome, I'd like to clarify that our current 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, which is quoted at $180,000 total. Have we allocated sufficient budget for this? Also, are there any updates on the MPA submission and the planned discretionary cut for ratings clearance?

--- Round 3 ---
[R3.1] Theatrical & Windowing Strategy Director (speak, public): We've got a complex decision ahead. Our current plan is to release the film wide on Oct 9, 2026, with a 45-day exclusive window, but we're considering a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. I'd like to discuss the potential impact on our marketing ROI and any contractual implications. Can you provide more insight into how our marketing efforts could be affected by a change in release strategy, and are there any specific contractual implications or legal constraints we should be aware of?
[R3.2] Marketing Analytics & Media Planning Lead (speak, public): To better assess the impact of a hybrid theatrical-to-PVOD window on our marketing ROI, I'd like to discuss how our current ad placement compliance guardrails and influencer partnerships might be affected. We've whitelisted 48 channels and have an exclusion list of 120 keywords. Additionally, we've seeded 35 influencers with an embargo lift on Sep 20, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R3.3] Legal & Business Affairs Counsel (speak, public): To ensure we're compliant and optimizing our commercial outcome, I'd like to confirm if there are any contractual obligations tied to our influencer partnerships and if altering our release strategy would trigger any internal thresholds or partner disputes. Additionally, can you clarify the current status of the trailer music licensing and the MPA submission for ratings clearance?

--- Round 4 ---
[R4.1] Theatrical & Windowing Strategy Director (speak, public): To better understand the implications of altering our release strategy, I'd like to clarify the current status of our international presales and delivery commitments. We've got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Are there any potential contractual penalties or obligations we should be aware of if we change our release strategy?
[R4.2] Marketing Analytics & Media Planning Lead (speak, public): To assess the impact of altering our release strategy on our marketing ROI, I'd like to summarize our current marketing efforts and discuss potential contractual implications. Our paid media budget is $14.0M, with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also whitelisted 48 channels and have an exclusion list of 120 keywords for ad placement compliance. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R4.3] Legal & Business Affairs Counsel (speak, public): To ensure we're compliant and optimizing our commercial outcome, I'd like to confirm if there are any contractual obligations tied to our influencer partnerships and if altering our release strategy would trigger any internal thresholds or partner disputes. Additionally, can you clarify the current status of the trailer music licensing and the MPA submission for ratings clearance?

--- Round 5 ---
[R5.1] Theatrical & Windowing Strategy Director (speak, public): To make a final recommendation on our release strategy, I'd like to summarize our current understanding. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R5.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R5.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 6 ---
[R6.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R6.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R6.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 7 ---
[R7.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R7.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R7.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 8 ---
[R8.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R8.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R8.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 9 ---
[R9.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R9.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R9.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 10 ---
[R10.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R10.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R10.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 11 ---
[R11.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R11.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R11.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 12 ---
[R12.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R12.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R12.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 13 ---
[R13.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R13.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R13.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 14 ---
[R14.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R14.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R14.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 15 ---
[R15.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R15.2] Marketing Analytics & Media Planning Lead (speak, public): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R15.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 16 ---
[R16.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp- set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R16.2] Marketing Analytics & Media Planning Lead (speak, private to=Theatrical & Windowing Strategy Director,Legal & Business Affairs Counsel): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R16.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 17 ---
[R17.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R17.2] Marketing Analytics & Media Planning Lead (speak, private to=Theatrical & Windowing Strategy Director,Legal & Business Affairs Counsel): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R17.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 18 ---
[R18.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R18.2] Marketing Analytics & Media Planning Lead (speak, private to=Theatrical & Windowing Strategy Director,Legal & Business Affairs Counsel): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R18.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

--- Round 19 ---
[R19.1] Theatrical & Windowing Strategy Director (speak, public): To finalize our recommendation on the release strategy, let's summarize our key findings. We're considering a wide theatrical release on Oct 9, 2026, with a 45-day exclusive window, versus a hybrid theatrical-to-PVOD window with PVOD availability on day 18. Our T-30 presales are at 62,000 tickets, below the comp-set median of 95,000. We've also got a minimum guarantee of $4.2M from UK/Ireland, with delivery due on Sep 5, 2026. Can we confirm if there are any contractual obligations or legal constraints tied to our influencer partnerships and other commercial commitments that we should be aware of when considering a change in our release strategy?
[R19.2] Marketing Analytics & Media Planning Lead (speak, private to=Theatrical & Windowing Strategy Director,Legal & Business Affairs Counsel): To finalize our recommendation on the release strategy, let's summarize our key considerations. Our current marketing efforts include a $14.0M paid media budget with 60% allocated to digital video, and we've seeded 35 influencers with an embargo lift on Sep 20, 2026. We've also implemented ad placement compliance guardrails with 48 whitelisted channels and 120 excluded keywords. A hybrid theatrical-to-PVOD window could potentially impact our marketing ROI and influencer partnerships. Can we confirm if there are any contractual obligations or legal constraints tied to these partnerships that we should be aware of when considering a change in our release strategy?
[R19.3] Legal & Business Affairs Counsel (speak, public): To finalize our recommendation on the release strategy, I'd like to confirm that we've addressed all contractual and legal considerations. We've confirmed our 45-day exclusive theatrical window meets the ≥31-day requirement for the 5 major chains. Additionally, we need to finalize the trailer music licensing by clearing the 2 remaining tracks, quoted at $180,000 total. Are there any updates on the MPA submission and the planned discretionary cut for ratings clearance? Also, have we assessed any potential contractual penalties or obligations tied to our influencer partnerships and other commercial commitments if we alter our release strategy?

